Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 38 | 2025 | 320 | 14.920 |
Why?
|
| Laparoscopy | 55 | 2025 | 780 | 13.640 |
Why?
|
| Robotics | 31 | 2023 | 270 | 10.650 |
Why?
|
| Urologic Surgical Procedures | 32 | 2025 | 150 | 9.570 |
Why?
|
| Ureter | 23 | 2023 | 95 | 9.320 |
Why?
|
| Ureteral Obstruction | 19 | 2025 | 69 | 7.150 |
Why?
|
| Kidney Pelvis | 16 | 2025 | 50 | 4.970 |
Why?
|
| Urinary Bladder | 15 | 2025 | 249 | 4.240 |
Why?
|
| Cystostomy | 9 | 2018 | 15 | 3.940 |
Why?
|
| Replantation | 11 | 2022 | 36 | 3.890 |
Why?
|
| Urinary Bladder, Neurogenic | 9 | 2025 | 26 | 3.840 |
Why?
|
| Vesico-Ureteral Reflux | 8 | 2022 | 28 | 3.800 |
Why?
|
| Appendix | 8 | 2022 | 31 | 3.630 |
Why?
|
| Urology | 6 | 2024 | 121 | 3.340 |
Why?
|
| Child | 56 | 2025 | 7241 | 3.220 |
Why?
|
| Hydronephrosis | 6 | 2023 | 33 | 2.450 |
Why?
|
| Operative Time | 12 | 2025 | 149 | 2.380 |
Why?
|
| Urinary Diversion | 8 | 2019 | 42 | 2.310 |
Why?
|
| Nephrectomy | 11 | 2024 | 291 | 2.230 |
Why?
|
| Pediatrics | 6 | 2024 | 361 | 2.000 |
Why?
|
| Treatment Outcome | 34 | 2025 | 8295 | 1.740 |
Why?
|
| Infant | 21 | 2025 | 3189 | 1.570 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2023 | 99 | 1.510 |
Why?
|
| Retrospective Studies | 32 | 2025 | 9239 | 1.490 |
Why?
|
| Child, Preschool | 23 | 2025 | 3773 | 1.490 |
Why?
|
| Humans | 85 | 2025 | 90014 | 1.330 |
Why?
|
| Postoperative Complications | 14 | 2025 | 2317 | 1.290 |
Why?
|
| Length of Stay | 12 | 2025 | 751 | 1.250 |
Why?
|
| Urinary Reservoirs, Continent | 3 | 2020 | 14 | 1.230 |
Why?
|
| Kidney | 8 | 2023 | 1147 | 1.170 |
Why?
|
| Urinary Incontinence | 4 | 2020 | 214 | 1.160 |
Why?
|
| Urologic Diseases | 3 | 2018 | 44 | 1.130 |
Why?
|
| Kidney Diseases | 4 | 2014 | 320 | 1.080 |
Why?
|
| Learning Curve | 2 | 2025 | 20 | 1.010 |
Why?
|
| Clinical Competence | 2 | 2025 | 796 | 0.990 |
Why?
|
| Needles | 1 | 2024 | 40 | 0.930 |
Why?
|
| Adolescent | 20 | 2025 | 9352 | 0.920 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2025 | 71 | 0.910 |
Why?
|
| Appendectomy | 2 | 2016 | 39 | 0.890 |
Why?
|
| Foreign Bodies | 1 | 2024 | 66 | 0.870 |
Why?
|
| Urogenital Abnormalities | 2 | 2015 | 20 | 0.870 |
Why?
|
| Pneumoperitoneum | 1 | 2022 | 4 | 0.850 |
Why?
|
| Patient Positioning | 4 | 2018 | 65 | 0.830 |
Why?
|
| Ileum | 3 | 2015 | 168 | 0.810 |
Why?
|
| Urinary Bladder Diseases | 2 | 2016 | 41 | 0.800 |
Why?
|
| Anastomosis, Surgical | 5 | 2018 | 277 | 0.750 |
Why?
|
| Male | 35 | 2025 | 42705 | 0.740 |
Why?
|
| Female | 35 | 2025 | 46620 | 0.710 |
Why?
|
| Urinary Catheterization | 2 | 2020 | 36 | 0.700 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 332 | 0.690 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2019 | 4 | 0.690 |
Why?
|
| Puberty, Delayed | 1 | 2019 | 19 | 0.680 |
Why?
|
| Amenorrhea | 1 | 2019 | 28 | 0.680 |
Why?
|
| Mullerian Ducts | 1 | 2019 | 18 | 0.680 |
Why?
|
| Urography | 2 | 2018 | 45 | 0.680 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 106 | 0.630 |
Why?
|
| Patient Safety | 1 | 2020 | 219 | 0.570 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 56 | 0.560 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 110 | 0.540 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2016 | 6 | 0.540 |
Why?
|
| Urinary Tract Infections | 4 | 2022 | 76 | 0.530 |
Why?
|
| Urodynamics | 2 | 2013 | 123 | 0.510 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 233 | 0.480 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 3682 | 0.470 |
Why?
|
| Enema | 2 | 2022 | 39 | 0.470 |
Why?
|
| Diverticulum | 1 | 2015 | 45 | 0.470 |
Why?
|
| Editorial Policies | 1 | 2014 | 34 | 0.460 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2014 | 32 | 0.460 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2011 | 24 | 0.450 |
Why?
|
| Peritoneal Diseases | 1 | 2013 | 16 | 0.450 |
Why?
|
| Neural Tube Defects | 1 | 2013 | 45 | 0.430 |
Why?
|
| Hypogastric Plexus | 1 | 2012 | 4 | 0.420 |
Why?
|
| Colon | 1 | 2016 | 521 | 0.420 |
Why?
|
| Urinary Retention | 1 | 2012 | 42 | 0.420 |
Why?
|
| Urethra | 1 | 2013 | 115 | 0.410 |
Why?
|
| Prospective Studies | 6 | 2022 | 4326 | 0.410 |
Why?
|
| Suture Techniques | 2 | 2010 | 144 | 0.400 |
Why?
|
| Prune Belly Syndrome | 1 | 2011 | 3 | 0.390 |
Why?
|
| Surgically-Created Structures | 1 | 2011 | 5 | 0.380 |
Why?
|
| Infant, Newborn | 5 | 2025 | 2494 | 0.380 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 540 | 0.380 |
Why?
|
| Ostomy | 1 | 2011 | 15 | 0.370 |
Why?
|
| Stents | 3 | 2021 | 412 | 0.340 |
Why?
|
| Preoperative Care | 2 | 2011 | 395 | 0.310 |
Why?
|
| Risk Assessment | 4 | 2019 | 2327 | 0.300 |
Why?
|
| Intestines | 1 | 2010 | 416 | 0.280 |
Why?
|
| Peritoneal Dialysis | 1 | 2007 | 31 | 0.270 |
Why?
|
| Postoperative Care | 2 | 2018 | 232 | 0.270 |
Why?
|
| Cathartics | 1 | 2006 | 27 | 0.270 |
Why?
|
| Ureteral Diseases | 1 | 2006 | 14 | 0.270 |
Why?
|
| Pilot Projects | 2 | 2023 | 872 | 0.270 |
Why?
|
| Reoperation | 3 | 2018 | 605 | 0.250 |
Why?
|
| Perioperative Care | 2 | 2018 | 171 | 0.250 |
Why?
|
| Urination | 1 | 2025 | 39 | 0.240 |
Why?
|
| United States | 6 | 2018 | 7115 | 0.230 |
Why?
|
| Swine | 2 | 2018 | 591 | 0.230 |
Why?
|
| Feasibility Studies | 3 | 2012 | 784 | 0.230 |
Why?
|
| Pain, Postoperative | 2 | 2018 | 257 | 0.230 |
Why?
|
| Incidence | 3 | 2018 | 1604 | 0.220 |
Why?
|
| Diet | 1 | 2006 | 444 | 0.220 |
Why?
|
| Time Factors | 4 | 2020 | 5362 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 414 | 0.210 |
Why?
|
| Elective Surgical Procedures | 2 | 2021 | 129 | 0.200 |
Why?
|
| Cystography | 1 | 2021 | 6 | 0.190 |
Why?
|
| Blood Loss, Surgical | 2 | 2015 | 117 | 0.190 |
Why?
|
| Urologists | 1 | 2021 | 29 | 0.190 |
Why?
|
| Surgical Wound Infection | 2 | 2011 | 204 | 0.190 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 221 | 0.190 |
Why?
|
| Machine Learning | 1 | 2023 | 270 | 0.180 |
Why?
|
| Age Factors | 2 | 2016 | 1879 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 64 | 0.180 |
Why?
|
| Testis | 2 | 2017 | 152 | 0.180 |
Why?
|
| Pandemics | 3 | 2021 | 778 | 0.180 |
Why?
|
| Surgery Department, Hospital | 1 | 2020 | 44 | 0.170 |
Why?
|
| Forecasting | 1 | 2021 | 304 | 0.170 |
Why?
|
| Hypogonadism | 1 | 2019 | 40 | 0.170 |
Why?
|
| Vagina | 1 | 2021 | 177 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2019 | 69 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2020 | 115 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2020 | 125 | 0.160 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 157 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 124 | 0.160 |
Why?
|
| Cohort Studies | 2 | 2016 | 2886 | 0.150 |
Why?
|
| Spermatic Cord Torsion | 1 | 1998 | 4 | 0.150 |
Why?
|
| Surgical Flaps | 1 | 2021 | 250 | 0.150 |
Why?
|
| Outpatients | 1 | 2019 | 101 | 0.150 |
Why?
|
| Spinal Dysraphism | 1 | 2018 | 19 | 0.150 |
Why?
|
| Preoperative Period | 1 | 2018 | 94 | 0.150 |
Why?
|
| Prone Position | 2 | 2008 | 57 | 0.140 |
Why?
|
| Ovotesticular Disorders of Sex Development | 1 | 2017 | 4 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2018 | 301 | 0.140 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2017 | 11 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 149 | 0.140 |
Why?
|
| Health Care Rationing | 1 | 2017 | 83 | 0.140 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2016 | 5 | 0.140 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2016 | 41 | 0.130 |
Why?
|
| Urinary Catheters | 1 | 2016 | 6 | 0.130 |
Why?
|
| Ileostomy | 1 | 2016 | 29 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2016 | 258 | 0.130 |
Why?
|
| Patient Selection | 1 | 2020 | 682 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 608 | 0.130 |
Why?
|
| Estradiol | 1 | 2017 | 250 | 0.130 |
Why?
|
| Adult | 7 | 2017 | 26845 | 0.130 |
Why?
|
| Gastrostomy | 1 | 2016 | 70 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2019 | 543 | 0.130 |
Why?
|
| Radioisotope Renography | 1 | 2015 | 7 | 0.120 |
Why?
|
| Testosterone | 1 | 2017 | 272 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2015 | 171 | 0.120 |
Why?
|
| Age Distribution | 1 | 2015 | 199 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2018 | 355 | 0.120 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1995 | 77 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2016 | 301 | 0.120 |
Why?
|
| Decision Making | 1 | 2020 | 671 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 530 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2013 | 51 | 0.110 |
Why?
|
| Pelvis | 1 | 2014 | 96 | 0.110 |
Why?
|
| Tissue Adhesions | 1 | 2013 | 50 | 0.110 |
Why?
|
| Education, Medical | 1 | 2016 | 242 | 0.110 |
Why?
|
| Phenotype | 1 | 2019 | 2458 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 1075 | 0.110 |
Why?
|
| Young Adult | 3 | 2015 | 6423 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1703 | 0.100 |
Why?
|
| Electrophysiology | 1 | 2012 | 403 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2016 | 457 | 0.100 |
Why?
|
| Recurrence | 1 | 2015 | 1148 | 0.100 |
Why?
|
| Miniaturization | 1 | 2011 | 14 | 0.100 |
Why?
|
| Laparoscopes | 1 | 2011 | 15 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Vitiligo | 1 | 2011 | 17 | 0.090 |
Why?
|
| Urination Disorders | 1 | 2011 | 52 | 0.090 |
Why?
|
| Melanocytes | 1 | 2011 | 57 | 0.090 |
Why?
|
| Intraoperative Care | 1 | 2010 | 85 | 0.090 |
Why?
|
| Equipment Design | 1 | 2011 | 422 | 0.090 |
Why?
|
| Wolffian Ducts | 1 | 2009 | 7 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2011 | 151 | 0.080 |
Why?
|
| Technetium Tc 99m Mertiatide | 1 | 2008 | 1 | 0.080 |
Why?
|
| Prognosis | 1 | 2016 | 3794 | 0.080 |
Why?
|
| Risk Factors | 1 | 2018 | 5566 | 0.080 |
Why?
|
| Kidney Function Tests | 2 | 2005 | 115 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1063 | 0.070 |
Why?
|
| Animals | 3 | 2018 | 27551 | 0.070 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 198 | 0.070 |
Why?
|
| Ureterostomy | 1 | 2006 | 3 | 0.070 |
Why?
|
| Venae Cavae | 1 | 2006 | 12 | 0.070 |
Why?
|
| Renal Veins | 1 | 2006 | 28 | 0.070 |
Why?
|
| Dilatation, Pathologic | 1 | 2006 | 55 | 0.070 |
Why?
|
| Radiography | 1 | 2008 | 809 | 0.070 |
Why?
|
| Prostatectomy | 1 | 2009 | 475 | 0.060 |
Why?
|
| Wilms Tumor | 1 | 2004 | 38 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 103 | 0.060 |
Why?
|
| Cicatrix | 1 | 2022 | 68 | 0.050 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 32 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 35 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 185 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 523 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 151 | 0.040 |
Why?
|
| Oligospermia | 1 | 1998 | 4 | 0.040 |
Why?
|
| Telemedicine | 1 | 2021 | 195 | 0.040 |
Why?
|
| Infertility, Male | 1 | 1998 | 26 | 0.040 |
Why?
|
| Chromosomes, Human, Y | 1 | 2017 | 24 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.030 |
Why?
|
| Mosaicism | 1 | 2017 | 71 | 0.030 |
Why?
|
| Testicular Hydrocele | 1 | 1995 | 4 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 262 | 0.030 |
Why?
|
| Herniorrhaphy | 1 | 1995 | 91 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2658 | 0.030 |
Why?
|
| PUVA Therapy | 1 | 2011 | 24 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2011 | 44 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 187 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2011 | 105 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 195 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 261 | 0.020 |
Why?
|
| Antioxidants | 1 | 2011 | 226 | 0.020 |
Why?
|
| Vas Deferens | 1 | 2009 | 8 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 255 | 0.020 |
Why?
|
| Seminal Vesicles | 1 | 2009 | 39 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 726 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2011 | 458 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2329 | 0.020 |
Why?
|
| RNA | 1 | 2011 | 583 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 342 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2887 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2004 | 230 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 1183 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 1746 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 19269 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 26179 | 0.010 |
Why?
|